CELLUVISC

This brand name is authorized in Australia, Germany, Finland, France, Hong Kong, Ireland, Netherlands, Tunisia, United Kingdom, South Africa

Active ingredients

The drug CELLUVISC contains one active pharmaceutical ingredient (API):

1 Carmellose sodium UNII K679OBS311 - CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED

Carmellose sodium has no pharmacological effect. Carmellose sodium has a high viscosity resulting in an increased retention time on the eye. Read about Carmellose

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CELLUVISC Eye drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01XA20	Artificial tears and other indifferent preparations	S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2324H, 5505R
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 04145356, 04145379, 04922943, 04922966
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 039768
Country: FR	Base de données publique des médicaments	Identifier(s): 66976254
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 182980, 283988, 283989, 283991, 283993, 284036, 284037, 284041, 284043, 284045
Country: HK	Department of Health Drug Office	Identifier(s): 42106
Country: IE	Health Products Regulatory Authority	Identifier(s): 17007, 17061, 17062, 17070, 17083
Country: NL	Z-Index G-Standaard	Identifier(s): 14847175
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 68950
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5473151
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/15.4/0144